Christina E. DeRemer

Variability in the Calculation of Time in Therapeutic Range for the Quality Control Measurement of Warfarin

Safia Zafar Siddiqui, Christina E. DeRemer, Jennifer L. Waller et al. · Journal of Innovations in Cardiac Rhythm Management · 2018 · 31 citations · Full text

Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey

Hazem Elewa, Christina E. DeRemer, Kimble Keller et al. · Journal of Thrombosis and Thrombolysis · 2013 · 28 citations

Thrombosis, Patient Survey, Health Policy +7

Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes

Laura G. Stoudenmire, Christina E. DeRemer, Hazem Elewa · International Journal of Hematology · 2014 · 21 citations

Thrombosis, Disease Management, Versus Office-based Management +10

Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study

Christina E. DeRemer, Scott Martin Vouri, Jingchuan Guo et al. · Journal of Diabetes and its Complications · 2021 · 21 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +7

Transitioning ambulatory care pharmacy services to telemedicine while maintaining multidisciplinary collaborations

Christina E. DeRemer, Jennifer Reiter, Jeffrey L. Olson · American Journal of Health-System Pharmacy · 2020 · 15 citations

Family Medicine, Clinical Specialties, Allied Health Professions +28